GeneDx CFO Sells $557K in Shares as Analysts Hold Positive Views
GeneDx Holdings Corp CFO Kevin Feeley sold 7,718 Class A shares on March 26, 2026, generating about $557,051 in proceeds. The sales coincided with a 17% drop in the stock over the preceding week. Feeley also exercised restricted stock units the same day for 16,250 shares at no cost and now directly holds 34,580 shares. The company reported strong f…